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OBJECTIVE MEASUREMENT OF STRESS
Psychological stress influences levels of quality
of life. Moreover, stress has been implicated in the
pathogenesis of various psychiatric and psychosomatic
disorders. Precise assessment of stress is an imminent
issue to deal with stress-related social, medical and
psychological problems. While most studies utilize
subjective questionnaires for the assessment of psy-
chological stress, some objective methods has been
introduced. Psychological stress is known to stimulate
the hypothalamus-pituitary-adrenal (HPA) axis, sympa-
thetic nervous system, and immune system. These
systems interact with each other, leading to the complex
stress response (1, 2). In addition to corticotrophin-
releasing hormone, adrenocorticotropic hormone,
and glucocorticoids, physiological stress stimulates
production of cytokines and modifies inflammatory
and immune responses.Measurement of one of these
hormones or cytokines has been used to objectively
assess the levels of stress. However, their usefulness
as a biological marker is limited, because of the un-
satisfactory sensitivity and/or specificity.
One of the new approaches for the assessment of
stress response is to use DNA microarray. The mi-
croarray is an emerging technology that allows
simultaneous measurement of thousands of mRNA
transcripts in biologic samples. The microarray is
now recognized as a useful clinical device to make
diagnostic, therapeutic, or prognostic decisions for
patients. Considerable progress has already been made
in clinical cancer researches, using systematic analysis
of gene expression patterns to define tumor subtypes,
identify molecular markers, and investigate new
therapies (3-10). The examples of special note are
applications in the differential diagnosis of adult acute
leukemias (4) and the identification of clinical-outcome
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predictors in adult acute myeloid leukemia (5) and
breast cancer (6, 7). In addition to these applications,
high-throughput analysis of gene expression by mi-
croarray may have a potential advantage of being able
to study complex responses, such as psychological
stress response, in which the measurement of limited
numbers of gene products does not always reflect
the status.
Peripheral leukocytes produce various cytokines,
and proinflammatory cytokines, particularly gp130
family members, directly stimulate theHPA axis (11).
At the same time, leukocytes express receptors
for stress mediators, such as hormones, neuro-
transmitters, growth factors, and cytokines. Thus,
leukocytes may be a potential target for the evalu-
ation of psychological stress response. In a series
of studies, we have developed a cDNA array
specifically designed to measure the mRNA levels
of stress-related genes in peripheral blood leuko-
cytes (12).
DEVELOPMENT OF STRESS-SENSITIVE
MICROARRAY
Construction of stress microarray and data analysis
We started to list stress-related genes (stress hor-
mones, neurotransmitters, cytokines, growth factors,
receptors, signal transductionmolecules, transcription
factors, heat shock proteins, growth- or apoptosis-
associated factors, and metabolic enzymes) from
the UniGene database of the National Center for
Biotechnology Information (Ftp://ncbi.nlm.nih.gov.
repository/unigene/). Target sequences of the listed
genes were designed using original software (Hitachi,
Saitama, Japan), and we selected 1,467 genes that
were actually amplified by reverse transcriptase-PCR
using total RNA isolated from peripheral leukocytes
of healthy volunteers (see http : //www.hitachi.co.
jp/LS/ for the full list of genes). All PCR products
were sequenced to be the corresponding cDNAs, and
they were spotted on the array according to themethod
previously described (13). The microarray showed
high reproducibility with a mean coefficient of variation
of less than 20 %, and the dynamic ranges were three
orders of magnitude.
Signal intensities of Cy5 and Cy3 were quantified
and analyzed by subtracting the backgrounds, using
QuantArray software (GSI-Lumonics). The intensity
values for duplicate cDNA probes were averaged.
Following global normalization, we selected several
hundreds genes with a fluorescence intensity higher
than the cut-off value of 300 in both conditions (la-
beled with Cy5 or Cy3). The relative expression
values (Cy5/Cy3) for these genes were subjected to
hierarchical clustering usingGeneSpring 6.0 software
(Silicon Genetics, Redwood City, CA, USA) and
similarity analysis by standard correlation. After
Cy5/Cy3 ratios of these genes were transformed
to logarithms, data were statistically analyzed.
Effect of leukocyte preparation on gene expression profiles
Freshly isolated or cultured mononuclear cells
are usually used to examine target genes relevant
to disease pathogenesis (14). These preparations are
also applied to expression analysis with microarray.
It recently became possible to directly prepare RNA
from whole blood using a commercially available kit,
which may eliminate non-specific changes in mRNA
levels during preparations (15, 16). WhenmRNA levels
in isolated leukocytes (mixture ofmononuclear cell- and
neutrophil-rich fractions) were compared with those
prepared from whole blood, the isolation procedures
increased the expression values of 52 genes > 2-folds
and decreased those for 10 genes to < 50 %. Thus, the
isolation procedures, such as mechanical stimuli,
significantly altered expression of stress-responsive
genes. Whitney et al. also suggested that excessive
in vitro handling required for isolation of monocytes
from peripheral blood leads to a gene expression
“signature” of cell stress, including up-regulation of
v-fos (FOS), CD83 and CD69, tumor necrosis factor
(TNF)-α induced protein 3 (TNFAIP3), DUSP2 (17).
Based on this information, together with our findings,
RNA samples directly prepared from whole blood
were used to correctly assess the stress response
in the following experiments.
Effects of exercise and daily activity
We examined how physical exercise affected the
gene expression in peripheral leukocytes. Treadmill
exercises under aerobic conditions (< 60% of VO2
max for 1 h) did not change the expression pattern
in 5 healthy volunteers, although exhaustive exercise
with treadmill significantly changed it. We identified
26 geneswhose expressionswere significantly changed
after the exhaustive exercise.
We also examined whether routine works affected
the gene expression in peripheral leukocytes in daily
life. It was suggested that lunch or dinner transiently
changed the mRNA levels of 11 genes, such as IL-2
receptor β chain (IL2RB), MYB-related gene BMYB
(MYBL2), IL-7 receptor (IL7R), general transcription
factor IIF (GTF2F1), interferon inducible mRNA
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fragment (G1P3), telomerase reverse transcriptase
(TERT ), phosphoinositide 3-kinase-associated p85
(PIK3R1), T-cell specific protein (RANTES ), CDC-
like kinase (CLK1), dihydropyrimidine dehydrogenase
(DPYD ), KIAA0822 protein (ABCA8). But other
daily activities had no effect. In contrast, we confirmed
that mRNA levels for the selected 70 genes were
stable in daily life ; diet, classworks, or light exercises
did not significantly alter their mRNA levels.
Assessment of stress with the stress-sensitive microarray
We asked graduate students who would take the
final examination for the PhD to participate in this
study. They were in good physical health, were taking
no medication, and had no history of psychiatric or
somatic diseases. The final examination consisted of
an oral presentation of the PhD theses and a question-
and-answer session. Venous blood (10ml) was taken
from each subject 2 h before and 2 or 24 h after the
examination. The sample collected 4 wk before the
presentation was used as a reference. All blood samples
were collected under fasting conditions.
Hierarchical cluster analysis of the relative expression
values identified two groups of genes, whose expres-
sions were uniformly up-regulated or down-regulated
at 2 h after the presentation. Most of the expression
levels returned to the baseline within 24 h after the
examination. Bayesian t -test (error rate = 0.05) iden-
tified 70 genes whose mRNA levels were significantly
changed at 2 h after the examination.
The neuroendocrine response, activated by psycho-
logical stress, converts stress into changes in mono-
nuclear cell functions (18), and stimulates the
production of TNF-α, IL-6, IL-1 receptor antagonist,
interferon (IFN)-γ. and IL-10 (19). The significantly
up-regulated genes included receptors for these
cytokines and their associated molecules : IL-1 re-
ceptor (IL1R1 and IL1R2), TNF receptor homo-
logue (TNFRSF10C), TNF-α -inducedprotein (TNFAIP6),
IFN-γ receptor 2 (IFNGR2), interferon (IFN)-induced
cellular resistance mediator protein (MX2), IFN-
regulatory factor-2 (IRF2), and IFN-inducible proteins
(IFITM1 and IFITM3). This suggests that the
stress-responsive cytokines may stimulate their
receptor signals in peripheral leukocytes in response
to the stress. In addition, the stressful event significantly
up-regulated the expression values of several other
cytokine/chemokine receptors and their related
genes, such as colony-stimulating factor receptors
(CSF2R and CSF3), IL17R , IL8RA , IL8RB ,
chemokine ligands (SCYB5 and GRO1), Fc frag-
ment of IgG (FCGR2B ), IL-regulated nuclear
factor (NFIL3), and selectin L (SELL).
The mRNAs for stress-mediatingmolecules including
hypoxia-inducible factor 1 (HIF1A), FOS , and p38
MAP kinase (MAPK14), as well as those for heat
shock protein 70 members (HSPA6 and HSPA1A),
were also significantly up-regulated. The activation
of catecholamine receptors and glucocorticoid receptor
indirectly or directly modifies the transcription of
various genes (20, 21). Psychological stress rapidly
and transiently activates nuclear factor-κB, a hallmark
of inflammatory responses (22), in association with
elevated levels of catecholamines and cortisol (18).
Thus, psychological stress activatesmultiple signaling
pathways ; therefore it is difficult to fully explain the
biological significance of several other genes. With
regard to the significantly down-regulated genes,
however, the life event stress generally down-
regulated mRNA expression for growth-related genes
and cytochrome c oxidase subunits.
BIOLOGICAL MARKERSOF DEPRESSION
Depression affects about 10 % of the population
at some point in their life and is the leading cause of
disability in the nations with developed economies
(23). The disease is potentially fatal because 15% of
patients with severe depression eventually die by suicide
(24). If treated properly, most patients would recover
from the disease. However, studies have shown that
depression, which lacks specific objective findings,
is often missed or undiagnosed (25). Establishment
of convenient and reliable biological markers would
greatly improve the precise diagnosis andconsequently
the welfare of depressed patients.
Depression affects not only the mind but also the
entire organ systems through the interaction between
the brain and the body. There are convincing evidences
indicating endocrinological, immunological and auto-
nomic nervous system disturbances in depression (26).
A large number of studies have been conducted to
establish a diagnosticmarker by detecting one of these
systemic disturbances. One of the examples most ex-
tensively studied is the attempt to detect the hyperactivity
of HPA axis by using DST or its modification such
asDex/CRH test (27).Measurement of neurotransmitter
receptors or transporters located on the blood cells
have been also studied vigorously on the assumption
that they reflect to some extent their counterparts
in the CNS. For example, decreased 5HTT binding
have been reported in platelets of depressive patients
(28, 29), although some studies reported no change
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(30-32). More recently, with the progress of
experimental procedure, altered mRNA levels in
leukocytes have been reported, such as decreased
dopamine D4 receptormRNA levels (33) or increased
serotonin transporter mRNA levels (34) in major
depression and decreased CREB mRNA levels in
treated major depression (35). Our group has found
increased serotonin transporter mRNA levels in
leukocytes. Although these and other studies with
peripheral measures have contributed greatly to the
understanding of the mood disorders, its usefulness
as a biological marker in the clinical setting is limited,
because of the unsatisfactory sensitivity and/or speci-
ficity as well as the troublesome procedure requiring
the intense cooperation of patients.
ASSESSMENT OF DEPRESSION WITH
THE STRESS-SENSITIVE MICROARRAY
We have been exploring to establish a new bio-
logical marker of depression by profiling mRNA
expression from the leukocytes of the patients by
using the stress sensitive microarray. As is the case
with psychological stress, we predict that the char-
acteristic abnormalities in the neuroendocrine, neuro-
immune and autonomic nervous system in depression
should have effects on the expressional pattern of
mRNA in the leukocytes from depressed patients.
We have reported preliminary results with 32
patients (36). They met the criteria of Major De-
pressive Disorder according to Diagnostic and
Statistical Manual ofMental Disorders, FourthEdition
(37), aged from 18 to 65, with no psychiatric comor-
bidities, no serious somatic diseases, and no use of
antidepressants. Hamilton Rating Scale for Depression
(HAM-D) and Clinical Global Impression Scale (CGI)
were used for clinical evaluation. Peripheral blood
was collected before the treatment and expression
levels were compared with sex-and age-matched
healthy volunteers.
The microaray analysis revealed that expression
of a dozen of genes showed significant changes in
the total group of the patients comparedwith controls.
These genes may be useful as biological makers of
depression. In addition to these genes, there were
dozens of genes significantly altered in a half of the
patients compared with controls, thus dividing the
patients into two groups, although no symptomatic or
demographic variables could account for the dis-
tinction. Altered expression of genes of various cate-
gories in a subgroup of depression might be rele-
vant to the pathophysiology of this subgroup. It was
also of note that some of the altered genes before
treatment significantly changed toward the reverse
direction after treatment.
These preliminary results revealed sets of gene
expressions that could distinguish depressed patients
from controls. These alterations were different from
those observed in volunteers after stress or those in
preliminary samples of patients with schizophrenia.
Mechanisms of the alteration remain unclear. Neu-
rotransmitter, endocrinological and immunological
abnormalities are thought to have contributed to
the alteration of the expression to some extent. Some
of the alteration may directly reflect intracellular
abnormalities of depression that might be present
in the leukocytes. These altered genes provide clues
for elucidating molecular mechanisms of the disease.
The microarray method has a great advantage over
pervious biological markers in that it can utilize
hundreds of parameters from a small amount of pe-
ripheral blood cells. Thus, a complicated and probably
heterogeneous disease such as depression could be
adequately recognized. This approach has opened a
novel and promising horizon in the search of a bio-
logical marker of depression.
CONCLUSION
Adequate biological assessment of stress would
help to solve stress related social, medical and psy-
chological problems. High-throughput analysis of gene
expression by microarray may have a potential ad-
vantage of being able to study complex responses,
such as psychological stress response, in which the
measurement of limited numbers of gene products
does not always reflect the status. We developed a
cDNA microarray specifically designed to measure
the mRNA levels of stress-related genes in peripheral
blood leukocytes. Using this microarray, mRNA ex-
pressional change under stress was detected with
good sensitivity and specificity.Moreover, preliminary
results suggest that the array could differentiate
patients with depression from sex-and age-matched
control subjects. Thus, DNA microarray with stress-
related genes may provide a new biological maker
for stress response and stress-related disorders.
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